Trials / Completed
CompletedNCT04888728
To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers
An Open Label, 2-part, One-sequence, 3-period Study to Evaluate Drug-drug Interactions Between "DWN12088" and "Nebivolol" or "Paroxetine" in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
An open label, 2-part, one-sequence, 3-period study to evaluate drug-drug interactions between DWN12088 and nebivolol or Paroxetine in healthy volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWN12088 | Prolyl-tRNA synthetase (PRS) inhibitor |
| DRUG | Nebivolol | Nebivolol |
| DRUG | Paroxetine | Paroxetine |
Timeline
- Start date
- 2021-06-30
- Primary completion
- 2021-07-12
- Completion
- 2021-07-27
- First posted
- 2021-05-17
- Last updated
- 2021-08-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04888728. Inclusion in this directory is not an endorsement.